EMEA-001931-PIP02-19
Key facts
Active substance |
human fibrinogen
|
Therapeutic area |
Haematology-Hemostaseology
|
Decision number |
P/0352/2019
|
PIP number |
EMEA-001931-PIP02-19
|
Pharmaceutical form(s) |
Powder for solution for injection or infusion
|
Condition(s) / indication(s) |
Treatment of acquired fibrinogen deficiency
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Biotest AG
Tel. + 49 6103 801497 |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|